The SME IPO of Faalcon Concepts opened for subscription today and will close on April 23. The company aims to raise about Rs 12 crore through the SME IPO and list the shares on BSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue.
1) About Faalcon Concepts
Faalcon Concepts is engaged in designing, engineering, fabrication and installation of façade systems. The company said it believes in offering solutions to our customers with respect to their requirement of façade installation in complex projects. It also specialises in technically demanding facades.
2) Industry overview
The India facade market size reached $2,638.2 million in 2022. The market is expected to reach $4,254.5 million by 2028, exhibiting a growth rate (CAGR) of 8.23% during 2023-2028.
3) Faalcon Concepts IPO size
The IPO is entirely a fresh equity issue of 19.5 lakh shares and through the issue, the company aims to raise nearly Rs 12 crore.
4) Faalcon Concepts IPO price band
The company is offering its shares at Rs 62 apiece, and investors can bid for 2000 shares in 1 lot.
5) Faalcon Concepts IPO financial performance
For the period ended December 2023, the company clocked revenues of Rs 12.46 crore and net profit of Rs 1.31 crore.
6) Objects of the offer
The net proceeds from the public offer will be used to finance the capital expenditure for purchase of facade structural experiments, requirement of incremental working capital and general corporate purposes.
7) Lead managers and Registrar
Navigant Corporate Advisors is acting as the lead manager to the issue and Beetal Financial and Computer Services is the registrar.
8) Issue structure
About 50% of the offer is reserved for retail investors and the rest 50% for other investors.
9) Important dates
The IPO opened on April 19 and will close on April 23. The final allotment will likely be made on April 24. The company\’s shares will likely get listed on April 26.
10) Faalcon Concepts GMP
Ahead of the issue opening, the company\’s shares had no GMP in the unlisted market.
